144 related articles for article (PubMed ID: 20406935)
1. Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy.
Tlemcani K; Levine D; Smith RV; Brandwein-Gensler M; Staffenberg DA; Garg MK; Shifteh K; Haigentz M
J Clin Oncol; 2010 Aug; 28(24):e412-4. PubMed ID: 20406935
[No Abstract] [Full Text] [Related]
2. Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy.
Gangireddy Vg; Liles GB; Sostre GD; Coleman T
Clin Genitourin Cancer; 2012 Jun; 10(2):134-9. PubMed ID: 22409864
[No Abstract] [Full Text] [Related]
3. Axillary apocrine carcinoma with brain metastases.
Gallerani E; Ciriolo M; Rossini C; Cavalli F
J Clin Oncol; 2007 Dec; 25(35):5655-6. PubMed ID: 18065737
[No Abstract] [Full Text] [Related]
4. Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma.
Gong Y; Ren L; Zhou L; Zhu J; Huang M; Zhou X; Wang J; Lu Y; Hou M; Wei Y
Cancer Chemother Pharmacol; 2009 Jul; 64(2):327-33. PubMed ID: 19048253
[TBL] [Abstract][Full Text] [Related]
5. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
[TBL] [Abstract][Full Text] [Related]
6. Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
Rossi D; Dennetta D; Ugolini M; Alessandroni P; Catalano V; Fedeli SL; Giordani P; Casadei V; Baldelli AM; Graziano F; Catalano G
Clin Lung Cancer; 2008 Sep; 9(5):280-4. PubMed ID: 18824450
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
Chiappori AA; Haura E; Rodriguez FA; Boulware D; Kapoor R; Neuger AM; Lush R; Padilla B; Burton M; Williams C; Simon G; Antonia S; Sullivan DM; Bepler G
Clin Cancer Res; 2008 Mar; 14(5):1464-9. PubMed ID: 18316570
[TBL] [Abstract][Full Text] [Related]
8. A case of rapidly growing ovarian squamous cell carcinoma successfully controlled by weekly paclitaxel-carboplatin administration.
Ohtani K; Sakamoto H; Masaoka N; Shimada K; Kanaeda T; Kurihara M; Nagai N; Satoh K
Gynecol Oncol; 2000 Dec; 79(3):515-8. PubMed ID: 11104632
[TBL] [Abstract][Full Text] [Related]
9. A phase II trial of paclitaxel and cisplatin in patients with advanced squamous-cell carcinoma of the esophagus.
Zhang X; Shen L; Li J; Li Y; Li J; Jin M
Am J Clin Oncol; 2008 Feb; 31(1):29-33. PubMed ID: 18376224
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy for advanced adenocarcinoma of the skin: experience with combination chemotherapy and a review of the literature].
Yamazaki N
Gan To Kagaku Ryoho; 1997 Jan; 24(1):30-6. PubMed ID: 9020942
[TBL] [Abstract][Full Text] [Related]
11. Feasibility and pharmacokinetics of paclitaxel, carboplatin, and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck and for regionally advanced non-small cell lung cancer.
Aisner J; Belani CP; Kearns C; Conley B; Hiponia D; Engstrom C; Zuhowski E; Egorin MJ
Semin Oncol; 1995 Oct; 22(5 Suppl 12):17-21. PubMed ID: 7481856
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of paclitaxel and carboplatin in a hemodialysis patient with metastatic urothelial carcinoma--a case report].
Furuya Y; Takihana Y; Araki I; Tanabe N; Takeda M
Gan To Kagaku Ryoho; 2003 Jul; 30(7):1017-20. PubMed ID: 12894722
[TBL] [Abstract][Full Text] [Related]
13. [A case of recurrent pulmonary lymphoepithelioma-like carcinoma responding to treatment with CBDCA/paclitaxel combined chemotherapy].
Abe T; Tanabe Y; Watanabe S; Fujita N; Matsumoto N; Moriyama H; Kagamu H; Yokota T; Yoshizawa H; Gejyo F
Gan To Kagaku Ryoho; 2004 Aug; 31(8):1215-7. PubMed ID: 15332546
[TBL] [Abstract][Full Text] [Related]
14. Multi-center study of two dose levels of paclitaxel with carboplatin in locally advanced and metastatic non-small cell lung cancer (NSCLC).
Glorieux P; Ortmanns P; Marien S; Degives R; Degraeve D; Potvin M; Grauwels D; Schallier D
Anticancer Res; 2001; 21(2B):1487-94. PubMed ID: 11396237
[TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson syndrome induced by paclitaxel in a patient with squamous cell carcinoma of the lung: a case report.
Hiraki A; Aoe K; Murakami T; Maeda T; Eda R; Takeyama H
Anticancer Res; 2004; 24(2C):1135-7. PubMed ID: 15154637
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary report.
Lee JS; Pisters KM; Komaki R; Glisson BS; Khuri FR; Schea R; Fossella FV
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-52-S12-55. PubMed ID: 9331122
[TBL] [Abstract][Full Text] [Related]
17. Long-term complete response to carboplatin plus paclitaxel combined with bevacizumab in a patient with metastatic spindle cell carcinoma.
Sakata S; Saeki S; Sato R; Ishizuka S; Sasaki J; Fujii K
Respir Investig; 2017 Nov; 55(6):372-375. PubMed ID: 29153418
[TBL] [Abstract][Full Text] [Related]
18. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel.
Socinski MA; Schell MJ; Bakri K; Peterman A; Lee JH; Unger P; Yates S; Hudgens S; Kies MS
Cancer; 2002 Sep; 95(6):1265-73. PubMed ID: 12216094
[TBL] [Abstract][Full Text] [Related]
19. [Squamous cell carcinoma, basal cell carcinoma].
Ikeda S; Suzuki T; Kiyohara Y; Kuramochi A
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1293-301. PubMed ID: 7688499
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of metastatic esthesioneuroblastoma.
de Vos FY; Willemse PH; de Vries EG
Neth J Med; 2003 Dec; 61(12):414-6. PubMed ID: 15025418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
